Bausch + Lomb Corporation (BLCO)
Last updated: 2026-10-21 21:58:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Bausch + Lomb Corporation (BLCO) operates in the OPHTHALMIC GOODS sector and is listed on NYSE. The stock is currently priced at $17.16, with a market capitalization of $5.93B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.44 to $18.92. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$5.93B | |
$16.89 | |
$21.95 | |
$10.45 | |
$16.93 | |
393.33K | |
451.06K | |
-- | |
$18.92 | |
$14.44 | |
-- | |
-- |
Bausch + Lomb Corporation (BLCO) After-Hours Stock Price
Bausch + Lomb Corporation (BLCO) is trading at $17.17 in after-hours trading as of 2026-10-21 21:19:52, up 1.42% ($0.24) from the regular-session close of $16.93.
After-hours trading shows how investors are pricing BLCO after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Bausch + Lomb Corporation (BLCO) 7-Day Stock Price Change
Over the past seven days, Bausch + Lomb Corporation (BLCO) moved from $16.07 to $17.16, representing a gain of 6.81% ($1.09).
The stock traded between $15.47 and $17.22 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 919.48 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
BLCO 52-Week Price Position
Position in Range: 60.9%
BLCO is currently trading at $17.16, placing it 60.9% of the way from its 52-week low of $14.44 to its 52-week high of $18.92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Bausch + Lomb Corporation (BLCO)?
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Bausch + Lomb Corporation Information
| Industry | OPHTHALMIC GOODS |
| Employees | 13000 |
| Exchange | NYSE |
| Company Website |
How to Buy Bausch + Lomb Corporation (BLCO) Stock on MEXC
Eligible investors can buy real shares of Bausch + Lomb Corporation (BLCO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Bausch + Lomb Corporation (BLCO) stock price today?
2.Is BLCO stock going up or down today?
3.What is BLCO pre-market price?
4.What is BLCO after-hours price?
5.Is BLCO stock trading now?
6.Where does BLCO sit relative to its 52-week high and low?
7.What sector is Bausch + Lomb Corporation in?
8.What is Bausch + Lomb Corporation's market capitalization and where is it listed?
9.How is BLCO valued in terms of P/E ratio and EPS?
10.Does Bausch + Lomb Corporation pay a dividend?
Explore More US Stocks
Search Stocks
BLCO Stock Calculator
Estimate the value between BLCO shares and USD.
BLCO Shares to USD
1.00 BLCO shares = 17.164 USD
Calculations are estimates based on the latest available price and are for reference only.


